~," Xanthine oxidase activity in the rat brain was measured by means of high-performance liquid chromatography with electrochemical detection of uric acid. Cerebral ischemia was produced by a four-vessel occlusion method. In the control rat, the enzyme activity was 0.87 _+ 0.13 nmol/gm wet weight/min at 25~ (mean + standard deviation), of which 92.4% was associated with the nicotinamide adenine dinucleotide (NAD)-dependent dehydrogenase form and only 7.6% with the oxygen-dependent superoxide-producing oxidase form. However, the ratio of the latter form increased to 43.7% after 30 minutes of global ischemia, despite the total xanthine oxidase activity remaining the same. Thus, it was revealed that uric acid can be synthesized in the rat brain and that cerebral ischemia induced the conversion of xanthine oxidase from an NAD-dependent dehydrogenase to an oxygen-dependent superoxide-producing oxidase. Although the xanthine oxidase pathway has been proposed as a source of oxygen-derived free radicals in various ischemic organs other than brain, the results of the present study suggest the involvement of the oxygen free radicals generated from this pathway in the pathogenesis of the ischemic injury of the rat brain.
O XYGEN-DERiVED free radicals have been implicated in various pathological conditions including ischemia. Particular attention has been focused on the enzyme, xanthine oxidase, because of the ability of this enzyme to serve as a source of oxidizing agents such as superoxide radical and hydrogen peroxide. This enzyme catalyzes the conversion of hypoxanthine to xanthine and xanthine to urate, and is known to exist in tissue in two forms: a nicotinamide adenine dinucleotide (NAD)-dependent dehydrogenase (Type D) and an oxygen-dependent superoxide-producing oxidase (Type 0). 4 The Type D form of the enzyme appears to predominate in most tissues in normal physiological conditions.
Brain has been shown to have little or no xanthine oxidase activity,' '~'~ so no attention has been paid to the involvement of this enzyme in the free radicalinduced damage of the ischemic brain. Only a few investigators have demonstrated the presence of this enzyme in the brain; however, none has dealt with the relationship between the Type D and Type O forms in the brain. Recently, a more sensitive method for measuring the xanthine oxidase activity has been developed, using high-performance liquid chromatography (HPLC) with electrochemical detection (ECD). '~ This method allows detection of xanthine and urate in the fetomole range.
The present study investigated the existence of xanthine oxidase activity, the relationship between Type D and Type O, and the possible implication of this enzyme in free radical-derived ischemic brain damage.
Materials and Methods

Induction of lschemia
The experiments were performed on male Wistar rats, each weighing 250 to 300 gm. Cerebral ischemia was produced by a modification of the method described by Pulsinelli and Brierley. J ~ After anesthesia was induced with 50 mg/kg intraperitoneal pentobarbital, each rat was paralyzed with intraperitoneal administration of pancuronium bromide. Immediately after immobilization, tracheostomy was performed and the animal was artificially ventilated to maintain the arterial O~ tension above 100 mm Hg and the CO2 tension close to 35 mm Hg. A right femoral artery was cannulated for monitoring blood pressure and blood sampling for gas analysis. Body temperature was kept close to 37~ with a heating pad and lamp.
The rats were fixed in the prone position and their vertebral arteries were electrocauterized. Next, they were placed in the supine position and both carotid arteries were isolated and encircled with 10-0 monofilament nylon suture. Both ends of the suture were passed through a small Silastic tube, and circulation was interrupted by pulling both common carotid arteries into the tubes. Liquid nitrogen was applied for 5 minutes by the funnel-freezing method to the exposed calvaria after 30 minutes of global ischemia. 14 Brains of control animals were frozen in situ, while ventilation was maintained mechanically. In a cryostat at -30~ the brains were chiseled out and the dura and superficial vessels were removed. The excised specimens were kept in liquid nitrogen until analysis.
H P L C Procedure
The procedure for measuring uric acid was performed by a slight modification of the method using HPLC with ultraviolet (UV) detection and ECD. 13 The HPLC apparatus was composed of a Shimadzu LC-6A pump, an SIL-6A autoinjector, a Shimadzu SPD-6A UV absorbance detector, a Yanaco VMD-101 electrochemical detector, and a Shimadzu C-R4A computing integrator. The two detectors were connected sequentially. Detection of peaks was at 290 nm (absorbance) for UV detection and at +0.6 V (applied potential) for ECD. A reverse-phase column (25 cm x 4 mm inner diameter, 5-urn particle size) was used; the mobile phase comprised 0.1 M ammonium-phosphate aqueous buffer, which consisted of ultrapure phosphoric acid brought up to pH 4.8 with ammonium hydroxide. The flow rate was 1.0 ml/min and the volume injected was 20 ul. Peaks were quantified by peak area using external standards.
Xanthine Oxidase Assay
The xanthine oxidase assay was a modification of the method described by Della Corte and Stirpe. 4"2~ About 75 mg of cortical tissue from the frozen brains was homogenized for 15 seconds in 1.0 ml of ice-cold 0.1 M Tris-HC1 buffer (pH 8.1) containing 1 mM ethylenediaminetetra-acetic acid, 10 mM dithioerythritol, and 1 mM phenylmethylsulfonylfluoride, which were added to prevent enzyme conversion during purification of the tissue homogenate? The homogenates were centrifuged at 100,000 G for 30 minutes at 4~ The resulting supernatant was used for the assay. Xanthine oxidase activities were assayed by measuring the amount of uric acid which was produced both in the presence and in the absence of exogenous NAD. The reaction mixture consisted of 0.05 mM xanthine and 0.1 M Tris-HC1 buffer (pH 8.1), with or without 0.5 mM NAD.~3 The preparation with the NAD added to the reaction mixtures allowed for the measurement of total xanthine oxidase (Type D and Type O), and the preparation without NAD allowed for the measurement of Type O alone. The reaction mixture (100 ~zl) was added to 100 ~tl of the supernatant and then incubated at 25~ Incubation times were set at 20, 40, or 60 Y. Kinuta, et al. minutes. The reaction was terminated by adding 20 ~1 60% perchloric acid to the mixtures. Following centrifugation at 3000 rpm for 5 minutes, 20-ul aliquots of the acid supernatants were injected into the HPLC system. Xanthine oxidase activity was expressed as mlU/gm wet weight (1 mlU = 1 nmol urate production/rain at 250C).
Statistical Analysis
Results were expressed as means +_ standard deviations of five observations. The data were analyzed using a one-way analysis of variance. Table 1 shows the results of the rat brain enzyme assay. In the control group, the xanthine oxidase activity was 0.87 _ 0.13 mIU/gm wet weight. The majority (92.4%) of the xanthine oxidase was in the NADdependent dehydrogenase form (Type D), and only 7.6% of the enzyme was in the oxygen-dependent superoxide-producing oxidase form (Type O) (Figs. 1 and  2 ). There was no significant difference between the control and ischemic groups in total xanthine oxidase. However, the ratio of Type O increased to 43.7% 30 minutes after global ischemia. Thus, ischemia induced the conversion of xanthine oxidase from Type D to Type O in the rat brain. It has been shown that this conversion can be induced in vitro either by sulfhydryl oxidation or by incubation with a protease such as trypsin or chymotrypsin. 2~ The former action can be readily reversed with the addition of a strong reducing agent such as dithioerythritol, whereas the proteolytic conversion is irreversible. 42~ Therefore, the enzymatic conversion observed in this experiment was presumably the result of ischemia-induced activated-proteases, 6'~ because dithioerythritol was used in our homogenizing buffer.
Results
In this study, the enzymatic conversion was about 36% of the total xanthine oxidase activity after 30 minutes of global ischemia of the rat brain. Downey, et al.," reported that conversion in the rat heart was achieved in the first 5 minutes of ischemia and was limited to 25%. With regard to this incomplete conversion, they suspected the existence of one or more isozymes of xanthine dehydrogenase, which is resistant to conversion. Table 2 shows the xanthine oxidase activity in the rat brain reported by other investigators 2~~'2~ compared with our data. These activities vary widely; however, exact comparison is difficult because of differences in methodology, including incubation temperature and pH. The incubation pH used in this study (pH 8.1) is closer to the optimal pH for xanthine oxidase (pH 8.0 -~~ and 8.T') than pH 7.4 which is used in most other procedures. The incubation temperature of 25~ used in our study was chosen in order to estimate the in vivo condition of xanthine oxidase, because Type D can be transformed to Type O by incubation at 37~ 2~ Incubation at 25~ also allows easier expression of the results in terms of international units, l~'
Discussion
The striking finding in this study was the ischemiainduced conversion to Type O from Type D in rat brain. The increase in Type O suggests the possibility of increased production of superoxide anion radicals which cause deleterious tissue damage, if the special condition of reperfusion capability and reoxygenation to a tissue is satisfied 22 (the substrate for this enzyme, namely hypoxanthine, is accumulated during ischemiaJ~).
Xanthine oxidase has been shown to be located almost exclusively in the endothelial cellss The isolated microvessels of rat brain have been demonstrated to be enriched 3.7-fold in xanthine oxidase compared to a homogenate of cerebral cortex. -~ Therefore, the capillary is probably the prime site of oxygen-derived free radical reactions which are induced by the xanthine-xanthine oxidase system. The endothelial injury has been shown to cause an increase in capillary permeability; 5 thus, an early accompaniment of this pathogenesis may be related to the development of the ischemic injury of the rat brain such as edema. Indeed, the injection of exogenous xanthine oxidase with hypoxanthine and adenosine diphosphate-Fe + §247 into brain is reported to cause injury to brain capillaries and breakdown of the bloodbrain barrier. ~ Xanthine oxidase is the rate-limiting enzyme in nucleic acid degradation.'2 Since the conversion of xanthine to uric acid is irreversible, the final step of uric acid synthesis mainly determines whether purine degradation products can be reutilized for nucleotide synthesis. It has been unclear why the reduced adenine nucleotide pool due to ischemia shows only partial recovery after reperfusion, even though the energy charge can be restored to a near-normal level. '~ In the brain, the anabolic pathways for purines greatly predominate over the catabolic pathways that catalyze the formation of xanthine and uric acid, presumably due to the very high concentration of the salvage enzyme, hypoxanthine-guanine phosphoribosyltransferase. ~' Pathological conditions such as ischemia will probably lead the change in equilibration between anabolism and catabolism of purines in the brain tissue. The increased hypoxanthine induced by the degradation of high-energy phosphates due to ischemic impact may be either irreversibly degraded to xanthine and uric acid or reincorporated into the adenine nucleotide pool. 2 Therefore, the production of uric acid in tissue may lead to the reduction of the adenine nucleotide pool, because circulating hypoxanthine (the salvageable purine in plasma) is only a minor source of purines for brain. ~' The increase in uric acid level has been reported in rat brain after focal ischemia, 8 and we have also observed this increase. Thus, the presence of xanthine oxidase activity in brain tissue contributes to the regulation of purine metabolism in the rat brain. Contrary to most other mammalian species, xanthine oxidase activity is extremely low in human tissues. '2 With regard to human brain, there is no report in which the xanthine oxidase activity was measured. However, the formation of uric acid has not been detected in fresh human brain but it has been found in specimens 1 day after death. 8 Therefore, xanthine oxidase probably exists in human brain at a rather low level. The fact that the xanthine oxidase activity is extremely low in man is surprising, because of the wide and effective use of a well-defined xanthine oxidase inhibitor, allopurinol, in the therapy of human diseases such as gout. However, the effect of allopurinol on experimental myocardial infarctions is still controversial in the field of cardiology, 6~~ 13 and the results depend on the animal species and the ischemic model used in experiments.
In conclusion, the xanthine oxidase activity and its conversion from an NAD-dependent dehydrogenase to an oxygen-dependent superoxide-producing oxidase during global ischemia of the rat brain was verified. The contribution of this enzyme to the pathogenesis of the ischemic brain injury should be further investigated.
